Circulating tissue factor, tissue factor pathway inhibitor and D-dimer in umbilical cord blood of normal term neonates and adult plasma

Blood Coagulation and Fibrinolysis

Volumn 14, Issue 2, 2003, Pages 125-129

  Tay, Siow Phing ^a   Cheong, Soon Keng ^a   Boo, Nem Yun ^a  

^a DEPARTMENT OF PHARMACOLOGY   (Malaysia)

Author keywords

Adult plasma; D dimer; Tissue factor; Tissue factor pathway inhibitor; Umbilical cord blood

Indexed keywords

D DIMER; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; ARTICLE; BIRTH INJURY; BLOOD CLOTTING DISORDER; BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOLYSIS; HEMOSTASIS; HUMAN; NEWBORN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; QUANTITATIVE ANALYSIS; REFERENCE VALUE; UMBILICAL CORD BLOOD;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL BLOOD; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; INFANT, NEWBORN; LIPOPROTEINS; MALE; PREGNANCY; THROMBOPLASTIN;

EID: 0037298411     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200302000-00002     Document Type: Article

References (40)

1. Edgington TS, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost 1991; 66:67-79.
2. Ruf W, Edgington TS. Structural biology of tissue factor, the initiator of thrombogenesis in vivo. FASEB J 1994; 8:385-390.
3. Nemerson Y. Tissue factor and hemostasis. Blood 1988; 71:1-8.
4. Bach RR. Initiation of coagulation by tissue factor. Crit Rev Biochem 1988; 23:339-368.
5. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Am J Pathol 1989; 134:1087-1097.
6. McVey JH. Tissue factor pathway. Baillière's Clin Haematol 1999; 12:361-372.
7. McVey JH. Tissue factor pathway. Baillière's Clin Haematol 1994; 7:469-484.
8. Rapaport SI. The extrinsic pathway inhibitor: a regulator of tissue factor-dependent blood coagulation. Thromb Haemost 1991; 66:6-15.
9. Mosesson MW. Fibrin polymerization and its regulatory role in hemostasis. J Lab Clin Med 1990; 116:8-17.
10. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L. Maturation of the hemostatic system during childhood. Blood 1992; 80:1998-2005.
11. Reverdiau-Moalic P, Delahousse B, Body G, Bardos P, Leroy J, Gruel Y. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 1996; 88:900-906.
12. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, Powers P. Development of the human coagulation system in the full-term infant. Blood 1987; 70:165-172.
13. Chuansumrit A, Manco-Johnson MJ, Hathaway WE. Heparin cofactor II in adults and infants with thrombosis and DIC. Am J Hematol 1989; 31:109-113.
14. Nardi M, Karpatkin M. Prothrombin and protein C in early childhood: normal adult levels are not achieved until the fourth year of life. J Pediatr 1986; 109:843-845.
15. ème Congreso Internacional de Hemostasis y Trombosis del Grupo Claht, St Domingue, 29 May-2 June 1997 [abstract].
16. Reverdiau-Moalic P, Delahousse B, Body G, Bardos P, Leroy J, Gruel Y. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 1996; 88:900-906.
17. Warr TA, Warn-Cramer BJ, Rao LVM, Rapaport SI. Human plasma extrinsic pathway inhibitor activity: I. Standardization of assay and evaluation of physiologic variables. Blood 1989; 74:201-206.
18. Schneider DM, von Tempelhoff GF, Herrle B, Heilmann L. Maternal and cord blood hemostasis at delivery. J Perinat Med 1997; 25:55-61.
19. Albrecht S, Kotzsch M, Siegert G, Luther T, Großmann H, Großer M, Müller M. Detection of circulating tissue factor and factor VII in a normal population. Thromb Haemost 1996; 75:772-777.
20. Koyama T, Nishida K, Ohdama S, Sawada M, Murakami N, Hirosawa S, et al. Determination of plasma tissue factor antigen and its clinical significance. Br J Haematol 1994; 87:343-347.
21. Falciani M, Gori AM, Fedi S, Chiarugi L, Simonetti I, Dabizzi RP, et al. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients. Thromb Haemost 1998; 79:495-499.
22. Gando S, Nanzaki S, Morimoto Y, Kobayashi S, Kemmotsu O. Systemic activation of tissue-factor dependent coagulation pathway in evolving acute respiratory distress syndrome in patients with trauma and sepsis. J Trauma 1999; 47:719-723.
23. Kim HY, Song KS, Park YS, Yun Y-S, Shim WH. Changes of plasma tissue factor and tissue factor pathway inhibitor antigen levels and induction of tissue factor expression on the monocytes in coronary artery disease. Cardiology 2000; 93:31-36.
24. Misumi K, Ogawa H, Yasue H, Soejima H, Suefuji H, Nishiyama K, et al. Comparison of plasma tissue factor levels in unstable and stable angina pectoris. Am J Cardiol 1998; 81:22-26.
25. Quien ET, Morales E, Cisar LA, Kim HC, Cimini C, Saidi P, Philipp CS. Plasma tissue factor antigen levels in capillary whole blood and venous blood: effect of tissue factor on prothrombin time. Am J Hematol 1997; 55:193-198.
26. Shimura M, Wada H, Wakita Y, Nakase T, Hiyoyama K, Nagaya S, et al. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation. Am J Hematol 1997; 55:169-174.
27. Suefuji H, Ogawa H, Yasue H, Kaikita K, Soejima H, Motoyama T, et al. Increased plasma tissue factor levels in acute myocardial infarction. Am Heart J 1997; 134:253-260.
28. Wada H, Nakase T, Nakaya R, Minamikawa K, Wakita Y, Kaneko T, et al. Elevated plasma tissue factor antigen levels in patients with disseminated intravascular coagulation. Am J Hematol 1994; 46:232-236.
29. Wakita Y, Wada H, Nakase T, Nakasaki T, Shimura M, Hiyoyama K, et al. Aberrations of the tissue factor pathway in patients positive for lupus anticoagulant. Clin Appl Thromb/Hemost 1999; 5:10-15.
30. Ariëns RAS, Moia M, Rivolta E, Ponticelli C, Mannucci PM. High levels of tissue factor pathway inhibitor in patients with nephrotic proteinuria. Thromb Haemost 1999; 82:1020-1023.
31. Eling M, Stephens AC, Oragui EE, Rivers RPA, Levin M. Tissue factor pathway inhibitor (TFPI) levels in the plasma and urine of children with meningococcal disease. Thromb Haemost 2001; 85:240-244.
32. Falkon L, Gari M, Barbanoj M, Amiral J, Fontcuberta J. Tissue factor pathway inhibitor and anti-FXa kinetic profiles of a new low-molecular-mass heparin, Bemiparin, at therapeutic subcutaneous doses. Blood Coag Fibrinolysis 1998; 9:137-141.
33. Kamikura Y, Wada H, Yamada A, Shimura M, Hiyoyama K, Shiku H, et al. Increased tissue factor pathway inhibitor in patients with acute myocardial infarction. Am J Hematol 1997; 55:183-187.
34. Novotny WF, Brown SG, Miletich JP, Rader DJ, Broze GJ Jr. Plasma antigen levels of the lipoprotein-associated coagulation inhibitor in patient samples. Blood 1991; 78:387-393.
35. Roldán V, Fernández C, Marco P, Berdú J, De Paz F, Pascual E. Systemic lupus erythematosus patients have high amount of tissue factor pathway inhibitor (TFPI). Br J Haematol 1998; 102:134-135.
36. van der Bom JG, Bots ML, Haverkate F, Meijer P, Hofman A, Kluft C, Grobbee DE. Activation products of the haemostatic system in coronary, cerebrovascular and peripheral arterial disease. Thromb Haemost 2001; 85:234-239.
37. Koh SCL, Cheong YC, Arulkumaran S, Ratnam SS. Coagulation activation, fibrinolysis and inhibitors in neonates. Ann Acad Med Singapore 1997; 26:767-771.
38. Rapaport SI, Rao LVM. The tissue factor pathway: how it has become a 'prima ballerina'. Thromb Haemost 1995; 74:7-17.
39. Hudson IRB, Gibson BES, Brownlie J, Holland BM, Turner TL, Webber RG. Increased concentrations of D-dimers in newborn infants. Arch Dis Child 1990; 65:383-384.
40. Murtha AP, Boggess KA, Jimmerson CE, Greig PC, Herbert WNP. Umbilical venous D-dimer concentrations with and without labor. Obstet Gynecol 1998; 92:184-186.